Phase I trial of SAR 101099.

Trial Profile

Phase I trial of SAR 101099.

Phase of Trial: Phase I

Latest Information Update: 15 Feb 2012

At a glance

  • Drugs SAR 101099 (Primary)
  • Indications Diabetic nephropathies
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Feb 2012 New trial record
    • 31 Dec 2011 Status changed from recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top